Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: A population based study

Pediatric Blood and Cancer

Volumn 56, Issue 2, 2011, Pages 250-257

  Laurencikas, Evaldas ^a   Gavhed, Désirée ^a   Stålemark, Helen ^a   Hooft, Ingrid van't ^a   Prayer, Daniela ^b   Grois, Nicole ^c   Henter, Jan Inge ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

CNS; Incidence; LCH

Indexed keywords

SOMATOMEDIN C;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DIABETES INSIPIDUS; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; HYPOPITUITARISM; INCIDENCE; MALE; NERVE DEGENERATION; NEUROCHEMISTRY; NEUROPSYCHOLOGICAL TEST; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; PRIORITY JOURNAL; SYMPTOM;

BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INCIDENCE; INFANT; MAGNETIC RESONANCE IMAGING; MALE;

EID: 78650078511     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22791     Document Type: Article

References (43)

1. Arceci RJ. The histiocytoses: The fall of the Tower of Babel. Eur J Cancer 1999; 35: 747-767; discussion 767-749.
2. Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 247-258.
3. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995; 127: 1-11.
4. Henter JI, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol 2004; 50: 157-174.
5. Coury F, Annels N, Rivollier A, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 2008; 14: 81-87.
6. Komp DM. Long-term sequelae of histiocytosis X. Am J Pediatr Hematol Oncol 1981; 3: 163-168.
7. Komp DM, El Mahdi A, Starling KA, et al. Quality of survival in histiocytosis X: A Southwest Oncology Group study. Med Pediatr Oncol 1980; 8: 35-40.
8. Prosch H, Grois N, Prayer D, et al. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer 2004; 43: 594-599.
9. Bernstrand C, Sandstedt B, Ahstrom L, et al. Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre. Acta Paediatr 2005; 94: 1073-1084.
10. Haupt R, Nanduri V, Calevo MG, et al. Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 2004; 42: 438-444.
11. Mittheisz E, Seidl R, Prayer D, et al. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatr Blood Cancer 2007; 48: 50-56.
12. Nanduri VR, Bareille P, Pritchard J, et al. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol 2000; 53: 509-515.
13. Stein SL, Paller AS, Haut PR, et al. Langerhans cell histiocytosis presenting in the neonatal period: A retrospective case series. Arch Pediatr Adolesc Med 2001; 155: 778-783.
14. Willis B, Ablin A, Weinberg V, et al. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 1996; 14: 2073-2082.
15. Donadieu J, Rolon MA, Thomas C, et al. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: A population-based study. J Pediatr 2004; 144: 344-350.
16. Van't Hooft I, Gavhed D, Laurencikas E, et al. Neuropsychological sequelae in patients with neurodegenerative Langerhans cell histiocytosis. Pediatr Blood Cancer 2008; 51: 669-674.
17. Grois NG, Favara BE, Mostbeck GH, et al. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 287-305.
18. Prayer D, Grois N, Prosch H, et al. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. Am J Neuroradiol 2004; 25: 880-891.
19. Grois N, Tsunematsu Y, Barkovich AJ, et al. Central nervous system disease in Langerhans cell histiocytosis. Br J Cancer Suppl 1994; 23: S24-S28.
20. Maghnie M, Arico M, Villa A, et al. MR of the hypothalamic-pituitary axis in Langerhans cell histiocytosis. Am J Neuroradiol 1992; 13: 1365-1371.
21. Martin-Duverneuil N, Idbaih A, Hoang-Xuan K, et al. MRI features of neurodegenerative Langerhans cell histiocytosis. Eur Radiol 2006; 16: 2074-2082.
22. Saatci I, Baskan O, Haliloglu M, et al. Cerebellar and basal ganglion involvement in Langerhans cell histiocytosis. Neuroradiology 1999; 41: 443-446.
23. Stalemark H, Laurencikas E, Karis J, et al. Incidence of Langerhans cell histiocytosis in children: A population-based study. Pediatr Blood Cancer 2008; 51: 76-81.
24. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997; 29: 157-166.
25. Wnorowski M, Prosch H, Prayer D, et al. Pattern and course of neurodegeneration in Langerhans cell histiocytosis. J Pediatr 2008; 153: 127-132.
26. Grois N, Flucher-Wolfram B, Heitger A, et al. Diabetes insipidus in Langerhans cell histiocytosis: Results from the DAL-HX 83 study. Med Pediatr Oncol 1995; 24: 248-256.
27. Grois N, Potschger U, Prosch H, et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer 2006; 46: 228-233.
28. Maghnie M, Cosi G, Genovese E, et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000; 343: 998-1007.
29. Nanduri VR, Lillywhite L, Chapman C, et al. Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: A single-institution, cross-sectional study. J Clin Oncol 2003; 21: 2961-2967.
30. Prosch H, Grois N, Wnorowski M, et al. Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis. Am J Neuroradiol 2007; 28: 1022-1028.
31. Kaltsas GA, Powles TB, Evanson J, et al. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: Clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000; 85: 1370-1376.
32. Grois N, Prayer D, Prosch H, et al. Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 2005; 128: 829-838.
33. Nanduri VR, Jarosz JM, Levitt G, et al. Basilar invagination as a sequela of multisystem Langerhans' cell histiocytosis. J Pediatr 2000; 136: 114-118.
34. Mark LP, Haughton VM, Hendrix LE, et al. High-intensity signals within the posterior pituitary fossa: A study with fat-suppression MR techniques. Am J Neuroradiol 1991; 12: 529-532.
35. Maghnie M, Genovese E, Bernasconi S, et al. Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus. Am J Neuroradiol 1997; 18: 1749-1752.
36. Poe LB, Dubowy RL, Hochhauser L, et al. Demyelinating and gliotic cerebellar lesions in Langerhans cell histiocytosis. Am J Neuroradiol 1994; 15: 1921-1928.
37. Beard W, Foster DB, Kepes JJ, et al. Xanthomatosis of the central nervous system. Clinical and pathological observations of a case with a posterior fossa syndrome. Neurology 1970; 20: 305-314.
38. Allen CE, McClain KL. Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Nat Med 2009; 15: 483-484.
39. Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007; 13: 1173-1175.
40. Ganong WF. Circumventricular organs: Definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 2000; 27: 422-427.
41. van der Knaap MS, Arts WF, Garbern JY, et al. Cerebellar leukoencephalopathy: Most likely histiocytosis-related. Neurology 2008; 71: 1361-1367.
42. Gavhed D, Akefeldt SO, Osterlundh G, et al. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis. Pediatr Blood Cancer 2009; 53: 1264-1270.
43. Fernandez-Latorre F, Menor-Serrano F, Alonso-Charterina S, et al. Langerhans' cell histiocytosis of the temporal bone in pediatric patients: Imaging and follow-up. Am J Roentgenol 2000; 174: 217-221.